Alcon has launched Azarga (brinzolamide/timolol) for the reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension where monotherapy is inadequate.

Brinzolamide and timolol decrease elevated intraocular pressure (IOP) primarily by reducing aqueous humour secretion, but they do so by different mechanisms of action.

For patients for whom monotherapy provides insufficient IOP reduction, Azarga offers a convenient fixed combination eye drop.

View Azarga drug record

Further information: Alcon

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more